Travoprost/Timolol EG 40 µg/ml - 5 mg/ml eye drops sol. dropper cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

travoprost/timolol eg 40 µg/ml - 5 mg/ml eye drops sol. dropper cont.

eg sa-nv - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; travoprost 0,04 mg/ml - eye drops, solution - 40 µg/ml - 5 mg/ml - travoprost 0.04 mg/ml; timolol maleate 6.83 mg/ml - timolol, combinations

SANDOZ TRAVOPROST / TIMOLOL PQ SOLUTION Canada - English - Health Canada

sandoz travoprost / timolol pq solution

sandoz canada incorporated - travoprost; timolol (timolol maleate) - solution - 0.004%; 0.5% - travoprost 0.004%; timolol (timolol maleate) 0.5% - beta-adrenergic agents

DUOTRAV Israel - English - Ministry of Health

duotrav

novartis israel ltd - timolol as maleate; travoprost - ophthalmic solution - travoprost 40 mcg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intraocular pressure (iop) in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

APO-TRAVOPROST-TIMOLOL PQ SOLUTION Canada - English - Health Canada

apo-travoprost-timolol pq solution

apotex inc - timolol (timolol maleate); travoprost - solution - 0.5%; 0.004% - timolol (timolol maleate) 0.5%; travoprost 0.004% - beta-adrenergic agents

TRAVOPROST/TIMOLOL SANDOZ 40/5 travoprost 40 microgram/mL and timolol (as maleate) 5 mg/mL eye drop solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

travoprost/timolol sandoz 40/5 travoprost 40 microgram/ml and timolol (as maleate) 5 mg/ml eye drop solution bottle

novartis pharmaceuticals australia pty ltd - timolol maleate,travoprost -

Travoprost/Timolol EG 40 µg/ml - 5 mg/ml eye drops sol. dropper cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

travoprost/timolol eg 40 µg/ml - 5 mg/ml eye drops sol. dropper cont.

eg sa-nv - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; travoprost 0,04 mg/ml - eye drops, solution - timolol, combinations

DUOTRAV travoprost 0.004% and timolol 0.5% (as maleate) eye drop solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

duotrav travoprost 0.004% and timolol 0.5% (as maleate) eye drop solution bottle

novartis pharmaceuticals australia pty ltd - travoprost, quantity: 40 microgram/ml; timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: ethoxylated hydrogenated castor oil; sodium hydroxide; propylene glycol; hydrochloric acid; sodium chloride; mannitol; boric acid; purified water; polyquaternium-1 - duotrav is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension for whom single agent therapy provides insufficient intraocular pressure reduction.

APO-TRAVOPROST-TIMOP PQ SOLUTION Canada - English - Health Canada

apo-travoprost-timop pq solution

apotex inc - travoprost; timolol (timolol maleate) - solution - 0.004%; 0.5% - travoprost 0.004%; timolol (timolol maleate) 0.5% - beta-adrenergic agents

TIMOLOL MALEATE tablet United States - English - NLM (National Library of Medicine)

timolol maleate tablet

mylan pharmaceuticals inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 5 mg - timolol maleate tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. timolol is indicated in patients who have survived the acute phase of myocardial infarction, and are clinically stable, to reduce cardiovascular mortality and the risk of reinfarction. timolol is indicated for the prophylaxis of migraine headache. timolol maleate is contraindicated in patients with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second- and third-degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; hypersensitivity to this product.

TIMOLOL MALEATE tablet United States - English - NLM (National Library of Medicine)

timolol maleate tablet

avera mckennan hospital - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 5 mg - timolol maleate tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. timolol is indicated in patients who have survived the acute phase of myocardial infarction, and are clinically stable, to reduce cardiovascular mortality and the risk of reinfarction. timolol is indicated for the prophylaxis of migraine headache. timolol maleate is contraindicated in patients with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second- and third-degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; hypersensitivity to this product.